ENANTA PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
ENANTA PHARMACEUTICALS, INC (ENTA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 6.67 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 6.67M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 6.74M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 6.64M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 5.76M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
|---|---|
| 2026-06-30 | 6.67M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 6.74M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 6.64M shares 10-Q · filed 2026-02-11 |
| 2025-09-30 | 5.76M shares 10-K · filed 2025-11-19 |
| 2025-06-30 | 5.95M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 6.03M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 6.00M shares 10-Q · filed 2025-02-12 |
| 2024-09-30 | 5.18M shares 10-K · filed 2024-11-27 |
| 2024-06-30 | 5.24M shares 10-Q · filed 2024-08-07 |
| 2024-03-31 | 5.24M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 5.21M shares 10-Q · filed 2024-02-08 |
| 2023-09-30 | 4.37M shares 10-K · filed 2023-11-22 |
| 2023-06-30 | 4.46M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 4.52M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 4.51M shares 10-Q · filed 2023-02-08 |
| 2022-09-30 | 3.99M shares 10-K · filed 2022-11-23 |
| 2022-06-30 | 4.02M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 4.12M shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 4.18M shares 10-Q · filed 2022-02-10 |
| 2021-09-30 | 3.85M shares 10-K · filed 2021-11-24 |
| 2021-06-30 | 3.88M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 3.89M shares 10-Q · filed 2021-05-10 |
| 2020-12-31 | 3.79M shares 10-Q · filed 2021-02-09 |
| 2020-09-30 | 3.26M shares 10-K · filed 2020-11-25 |
| 2020-06-30 | 3.26M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 3.31M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 3.44M shares 10-Q · filed 2020-02-10 |
| 2019-09-30 | 2.97M shares 10-K · filed 2019-11-27 |
| 2019-06-30 | 2.98M shares 10-Q · filed 2019-08-09 |
| 2019-03-31 | 2.93M shares 10-Q · filed 2019-05-10 |
| 2018-12-31 | 3.06M shares 10-Q · filed 2019-02-08 |
| 2018-09-30 | 2.62M shares 10-K · filed 2018-11-29 |
| 2017-09-30 | 2.28M shares 10-K · filed 2017-12-11 |
| 2017-06-30 | 2.26M shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 2.31M shares 10-Q · filed 2017-05-10 |
| 2016-12-31 | 2.24M shares 10-Q · filed 2017-02-09 |
| 2016-09-30 | 1.77M shares 10-K · filed 2016-12-09 |
| 2016-06-30 | 1.75M shares 10-Q · filed 2016-08-09 |
| 2016-03-31 | 1.76M shares 10-Q · filed 2016-05-10 |
| 2015-12-31 | 1.89M shares 10-Q · filed 2016-02-09 |
| 2015-09-30 | 1.58M shares 10-K · filed 2015-12-11 |
| 2015-06-30 | 1.57M shares 10-Q · filed 2015-08-10 |
| 2015-03-31 | 1.51M shares 10-Q · filed 2015-05-08 |
| 2014-12-31 | 1.49M shares 10-Q · filed 2015-02-06 |
| 2014-09-30 | 1.21M shares 10-K · filed 2014-12-11 |
| 2014-06-30 | 1.22M shares 10-Q · filed 2014-08-12 |
| 2014-03-31 | 1.23M shares 10-Q · filed 2014-05-12 |
| 2013-12-31 | 1.65M shares 10-Q · filed 2014-02-13 |
| 2013-09-30 | 1.41M shares 10-K · filed 2013-12-18 |
| 2013-06-30 | 1.50M shares 10-Q · filed 2013-08-12 |
| 2013-03-31 | 1.68M shares 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |